Prestige Wealth Management Group LLC Tg Therapeutics, Inc. Transaction History
Prestige Wealth Management Group LLC
- $465 Million
- Q2 2025
A detailed history of Prestige Wealth Management Group LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 50 shares of TGTX stock, worth $1,707. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$1,707
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
407Shares Held
92.4MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$540 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$389 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$260 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$119 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$104 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.96B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...